2023 Saw Decline in BMI, Obesity Prevalence in the United States
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 23, 2024 -- Body mass index (BMI) and obesity prevalence declined in the United States in 2023, according to a research letter published online Dec. 13 in JAMA Health Forum.
Benjamin Rader, Ph.D., M.P.H., from Boston Children's Hospital, and colleagues examined national trends in BMI and obesity among U.S. adults between Jan. 1, 2013, and Dec. 31, 2023. The mean population BMI and percentage of adults with obesity were calculated annually.
Overall, 16,743,822 unique adults contributed 47,939,382 BMI measurements. The researchers observed an increase in mean population BMI annually from 2013 to 2021, followed by a plateauing in 2022, and a slight decrease in 2023 (29.65 to 30.23, 30.24, and 30.21, respectively). The percent changes of adults with obesity followed the same pattern. Obesity prevalence decreased in the South, among individuals aged 66 to 75 years, and among women. In a sensitivity analysis using unweighted data, the 2023 decline in prevalence of obesity was also seen. Glucagon-like peptide 1 receptor agonist (GLP-1 RA) dispensing differed by region in a subset of individuals with available 2023 insurance claims (South, 6.0 percent; Midwest, 5.1 percent; Northeast, 4.4 percent; West, 3.4 percent).
"These findings suggest that BMI and obesity prevalence in the U.S. decreased in 2023 for the first time in more than a decade," the authors write. "The most notable decrease was in the South, which had the highest observed per capita GLP-1RA dispensing rate."
One author disclosed ties to Optum.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Body Weight Cycling Tied to Increased Risk for Renal Events in Type 1 Diabetes
MONDAY, Feb. 10, 2025 -- For individuals with type 1 diabetes, intraindividual body weight variability, or body weight cycling, is associated with an increased risk for renal...
Salt Substitution Cuts Risk for Recurrent Stroke
MONDAY, Feb. 10, 2025 -- Salt substitution is safe and reduces the risk for stroke recurrence and death among patients with stroke, according to a study published online Feb. 5 in...
ASA: Mechanical Removal of Clot No Better Than Best Medical Treatment for Medium or Distal Vessel Occlusion
MONDAY, Feb. 10, 2025 -- Endovascular thrombectomy (EVT) does not lead to better outcomes at 90 days compared with usual care or best medical treatment for patients with acute...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.